"Treatment Algorithms: Colon Cancer - Treatment dictated by stage, prior therapy, and reimbursement" - New Market Report
The colon cancer pipeline has grown as pharmaceutical companies are attracted by the high incidence and success of other developers. Cytotoxics will remain an integral part of treatment, but with key brands expected to come off patent over the forecast period and the approval of new therapies, treatment of this growing market is set to evolve.
View full press release